Update on vascular disrupting agents for cancer therapy

By Korpanty Grzegorz   Brekken Rolf A  

Therapy, Vol. 8, Iss. 4, 2011-07 ,pp. : 403-413

Future Medicine

Access to resources Recommend Favorite

Impact of beam quality on megavoltage radiotherapy treatment techniques utilizing gold nanoparticles for dose enhancement

By Tsiamas Panagiotis   Liu Bo   Cifter Fulya   Ngwa Wilfred F   Berbeco Ross I   Kappas Constantin   Theodorou Kiriaki   Marcus Karen   Makrigiorgos Mike G   Sajo Erno   Zygmanski Piotr  

Physics in Medicine and Biology, Vol. 58, Iss. 3, 2013-02 ,pp. : 451-464

IOP Publishing

Access to resources Recommend Favorite

Oncogene-Directed Therapies as Modulators of Cancer Coagulopathy, Angiogenesis and Tumor-Vascular Interface

By  

Current Signal Transduction Therapy, Vol. 2, Iss. 2, 2007-01 ,pp. : 157-163

Bentham Science Publishers

Access to resources Recommend Favorite

Radiation dose enhancement at tissue-tungsten interfaces in HDR brachytherapy

By Han Z   Safavi-Naeini M   Alnaghy S   Cutajar DL   Guatelli S   Petasecca M   Malaroda A   Carrara M   Bucci J   Zaider M   Lerch MLF   Rosenfeld AB    

Physics in Medicine and Biology, Vol. 59, Iss. 21, 2014-11 ,pp. : 6659-6659

IOP Publishing

Access to resources Recommend Favorite

A review of vascular disrupting agents as a concomitant anti-tumour modality with radiation

By  

Journal of Radiotherapy in Practice, Vol. 12, Iss. 3, 2013-05 ,pp. : 255-262

Cambridge University Press

Access to resources Recommend Favorite